-
Markets
-
Aktien
Sustainable finance2025 Euronext ESG Trends ReportWeiterlesenA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesWeiterlesenThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeWeiterlesenInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Funds
-
Fixed Income
European Defence BondsGroupe BPCE lists the first bondWeiterlesenFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Structured Products
-
Derivatives
Where European Government Bonds Meet the FutureFixed Income derivativesWeiterlesenTrade mini bond futures on main European government bonds
-
Rohstoffe
- Übersicht
- Kurse überblick
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Delivery & settlement
- Specifications & arrangements
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesWeiterlesenEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Resources
Designed to help students navigate the complexities of financial marketsEuronext Trading gameWeiterlesenJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
SINCLAIR PHARMA
Identification
Symbol
SPH
ISIN code
GB0033856740
Trading location
Paris
ICB
Pharmaceuticals
Website address
www.sinclairpharma.com
Issuer website
http://www.sinclairpharma.com
Operation
IPO date
Do. 19/04/2007
IPO type
Cotation directe
IPO type
Initial Public offering
Catégorie
IPO
Operation procedure
Le 19 avril 2007 : Premières négociations des actions Sinclair Pharma plc sur Eurolist. Cours de référence : le cours de clôture des actions sur le LSE la veille du 19 avril 2007, converti en € (au taux de change indicatif diffusé par le BCE à 14h15 heure de Paris).
Broker to issue
AEK - Amsterdams Effectenkantoor
BNP Paribas Securities Services